Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 7Prostatic Neoplasms 3Myasthenia Gravis 3Lymphoma 3Plasmacytoma 2Paraproteinemias 2Neoplasms 2Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Leukemia, Plasma Cell 2Hemangioma 2Breast Neoplasms 2Anatomic Stage IV Breast Cancer AJCC v8 2Spinal Cord Compression 1Recurrence 1Radiation Injuries 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Germ Cell and Embryonal 1Nasopharyngeal Carcinoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hepatitis 1Head and Neck Neoplasms 1Glioma 1Gallstones 1Esophageal Stenosis 1

Interventions

Specimen Handling 9Practice Guidelines as Topic 9Standard of Care 8Early Intervention, Educational 5Taxes 4Paclitaxel 4Docetaxel 4pertuzumab 3pembrolizumab 3Trastuzumab 3Methods 3Magnetic Resonance Spectroscopy 3Interviews as Topic 3Educational Status 3Biopsy 3trastuzumab biosimilar HLX02 2PF-05280014 2Ontruzant 2Ogivri 2Minoxidil 2Letrozole 2High-Energy Shock Waves 2Cyclophosphamide 2Carboplatin 2Acupuncture Therapy 22C4 antibody 2regadenoson 1palbociclib 1nilotinib 1lorcaserin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anatomic Stage I Breast Cancer AJCC v8 × Steroids × Clear all
NCT07407920 2026-02-12

Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
120 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡